Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Woodsmoke Particulate + Hypertonic Saline [NA]

View source ↗

Summary

A completed UNC-sponsored clinical trial evaluating woodsmoke particulate exposure with hypertonic saline for airway inflammation has finished, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic Saline (Hypertonic saline)
  • Woodsmoke Particulate (woodsmoke particulate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Airway Inflammation | NA | Status: COMPLETED | Results posted: 2025-08-08